Clinical trial
Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer
NCT00170157
Study timeline
Study start (unknown)2004-06-01Date precision: month
Registry last updated2017-05-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Adenocarcinomaunresolved
Prostate Carcinomaunresolved
Recurrent Prostate Carcinomaunresolved
Stage III Prostate Cancerunresolved
Stage IV Prostate Cancerunresolved
Interventions
BicalutamideDRUG · verified · RxNorm: bicalutamide
FlutamideDRUG · verified · RxNorm: flutamide
Goserelin AcetateDRUG · verified · RxNorm: goserelin acetate
IpilimumabDRUG · verified · RxNorm: ipilimumab
Leuprolide AcetateDRUG · verified · RxNorm: leuprolide acetate
Sponsors & collaborators
Mayo Cliniclead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00170157 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.